IRIS - Res&Arch Institutional Research Information System - Research & Archive

COSTA, CINZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.345
EU - Europa 2.704
AS - Asia 2.586
SA - Sud America 535
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 9.231
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.256
SG - Singapore 1.138
IE - Irlanda 502
HK - Hong Kong 462
BR - Brasile 450
CN - Cina 420
IT - Italia 410
UA - Ucraina 311
RU - Federazione Russa 285
VN - Vietnam 271
FR - Francia 228
DE - Germania 226
SE - Svezia 224
FI - Finlandia 176
KR - Corea 121
GB - Regno Unito 108
NL - Olanda 52
CA - Canada 44
AR - Argentina 38
IN - India 29
MX - Messico 28
RO - Romania 28
PL - Polonia 24
JP - Giappone 23
AT - Austria 22
BE - Belgio 22
ID - Indonesia 21
TR - Turchia 19
ZA - Sudafrica 19
CZ - Repubblica Ceca 18
CH - Svizzera 16
LT - Lituania 15
BD - Bangladesh 11
ES - Italia 11
IQ - Iraq 11
VE - Venezuela 10
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 8
EC - Ecuador 7
GR - Grecia 6
LB - Libano 6
UY - Uruguay 6
AU - Australia 5
DZ - Algeria 5
EU - Europa 5
PY - Paraguay 5
CO - Colombia 4
EG - Egitto 4
KE - Kenya 4
KZ - Kazakistan 4
MA - Marocco 4
PE - Perù 4
PH - Filippine 4
PS - Palestinian Territory 4
BB - Barbados 3
BO - Bolivia 3
IL - Israele 3
RS - Serbia 3
SA - Arabia Saudita 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DM - Dominica 2
ET - Etiopia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
AD - Andorra 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NC - Nuova Caledonia 1
PT - Portogallo 1
Totale 9.224
Salva come PNG Salva come JPEG
Città #
Singapore 752
Chandler 566
Dublin 497
Hong Kong 460
Boardman 203
San Mateo 203
Jacksonville 171
Ashburn 164
Santa Clara 148
Altamura 137
Beijing 131
Perugia 128
Seoul 121
Medford 111
Dong Ket 108
Princeton 108
Lawrence 101
Moscow 93
Munich 91
Wilmington 86
Ann Arbor 82
Andover 74
Los Angeles 61
Ho Chi Minh City 59
Turku 58
Des Moines 51
Helsinki 48
Redmond 43
Piscataway 40
The Dalles 40
São Paulo 39
Hanoi 33
Amsterdam 31
London 28
New York 28
Frankfurt am Main 22
Rio de Janeiro 21
San Paolo di Civitate 21
Brussels 20
Saint Petersburg 19
Brooklyn 18
Bucharest 18
Nuremberg 18
Woodbridge 18
Norwalk 17
Tokyo 17
Warsaw 17
Montreal 16
Atlanta 15
Houston 15
Dallas 14
Johannesburg 14
Chennai 13
Denver 13
Falkenstein 13
Stockholm 13
Brasília 12
Chicago 12
Poplar 12
Boston 11
Orem 11
Campinas 10
Columbus 10
Izmir 10
Tianjin 10
Curitiba 9
Falls Church 9
Florence 9
Mexico City 9
Redwood City 9
Boydton 8
Jakarta 8
Belo Horizonte 7
Council Bluffs 7
Guarulhos 7
Naples 7
Olomouc 7
Rome 7
San Francisco 7
Toronto 7
Zhengzhou 7
Brno 6
Den Haag 6
Goiânia 6
Guangzhou 6
Haiphong 6
Milan 6
Phoenix 6
Shenzhen 6
Vienna 6
Ankara 5
Hefei 5
Joinville 5
Manchester 5
Querétaro 5
Recanati 5
Roubaix 5
Santiago 5
Shanghai 5
São Bernardo do Campo 5
Totale 5.772
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 194
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 128
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 121
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 120
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 108
Hippocampal epileptogenesis in autoimmune encephalitis 107
Levetiracetam-associated hyponatremia. 106
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 106
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 105
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 105
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 105
Brain arteriovenous malformations and seizures: an Italian study. 103
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 100
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 100
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 100
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 100
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 98
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 98
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 97
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 96
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 96
Plasticity and repair in the post-ischemic brain 96
Effect of psychotropic drugs on seizure threshold 94
Occipital arteriovenous malformations andmigraine. 93
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 93
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 91
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 91
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 90
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 90
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 90
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 88
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 86
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 85
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 85
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 85
Amyloid-β: a potential link between epilepsy and cognitive decline 85
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 84
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 84
Management of epilepsy in brain tumors 84
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. 83
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na(+)/K(+) ATPase. 83
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 83
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 82
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 82
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice. 80
Neural 17beta-estradiol facilitates long-term potentiation in the hippocampal CA1 region 80
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 79
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 78
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 76
Chronic cocaine prevents depotentiation at corticostriatal synapses. 75
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events? 75
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 75
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 74
Cortical spreading depression as a target for anti-migraine agents. 74
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 74
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 72
Obsessive-compulsive disorder and migraine with medication-overuse headache. 72
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies 70
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 70
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 70
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 69
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. 69
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 69
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 68
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice. 67
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 67
Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity 67
Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study 67
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 66
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study. 65
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 65
MBOAT7 encephalopathy: Characterizing the neurology and epileptology 64
Cannabidiol: metabolism and clinical efficacy in epileptic patients 64
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. 64
Clinical features and outcome of 6 new patients carrying de novoKCNB1gene mutations 64
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 64
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 64
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 64
Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study. 63
Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-β 63
Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. 62
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 62
Migraine and epilepsy: what value today? 62
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 62
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. 61
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 61
Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3 61
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 61
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. 60
Late-onset n-acetylglutamate synthase deficiency: Report of a paradigmatic adult case presenting with headaches and review of the literature 60
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 60
Dopaminergic and Behavioral Deficits Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 59
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. 59
Levetiracetam protects against kainic acid-induced toxicity. 59
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 59
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 59
IRF2BPL: A new genotype for progressive myoclonus epilepsies 58
Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a-/- mice 58
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis 58
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. 57
Totale 8.005
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.737
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021420 0 0 0 0 0 37 65 29 86 25 59 119
2021/2022901 15 168 30 42 33 13 13 262 19 54 124 128
2022/20231.831 118 377 33 150 165 195 0 67 656 8 45 17
2023/2024803 43 75 34 10 3 3 177 11 117 26 152 152
2024/20251.930 25 162 91 122 221 120 95 155 329 122 324 164
2025/20262.436 299 332 328 652 696 129 0 0 0 0 0 0
Totale 9.504